Novartis Finishes Up $51.6B Alcon Purchase
Swiss drug giant Novartis AG wrested full control of eye care company Alcon Inc. on Wednesday after almost a year of regulatory and shareholder battles in the $51.6 billion deal....To view the full article, register now.
Already a subscriber? Click here to view full article